S Nahum Goldberg Selected Research

liposomal doxorubicin (Doxil)

11/2017	Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
1/2014	Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.
7/2013	Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature.
6/2012	Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.
12/2011	Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?
4/2010	Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways.
11/2008	RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.
10/2005	Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
5/2005	Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.
10/2003	Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Nahum Goldberg Research Topics

Disease

97	Neoplasms (Cancer) 05/2022 - 03/2002
15	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2002
11	Necrosis 08/2015 - 03/2002
9	Breast Neoplasms (Breast Cancer) 06/2009 - 03/2002
8	Adenocarcinoma 11/2018 - 05/2007
8	Renal Cell Carcinoma (Grawitz Tumor) 12/2011 - 09/2004
7	Neoplasm Metastasis (Metastasis) 09/2021 - 06/2003
5	Sarcoma (Soft Tissue Sarcoma) 07/2006 - 07/2002
4	Inflammation (Inflammations) 01/2021 - 08/2015
4	Body Weight (Weight, Body) 06/2009 - 07/2006
3	Hypoxia (Hypoxemia) 01/2021 - 12/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2002
3	Carcinogenesis 01/2020 - 03/2012
3	Hyperthermia 01/2020 - 12/2008
2	Portal Hypertension 01/2021 - 07/2010
2	Residual Neoplasm 01/2021 - 06/2003
2	Liver Neoplasms (Liver Cancer) 01/2020 - 09/2002
2	Disease Progression 01/2019 - 06/2003
2	Kidney Neoplasms (Kidney Cancer) 11/2018 - 10/2010
2	Hypertension (High Blood Pressure) 07/2016 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 06/2007 - 05/2004
2	Abscess 03/2006 - 06/2002
1	Appendicitis 02/2022
1	AIDS-Related Complex (ARC) 01/2018
1	Medulloblastoma 10/2017
1	Chronic Disease (Chronic Diseases) 10/2017
1	Adenoma (Adenomas) 07/2016

Drug/Important Bio-Agent (IBA)

14	liposomal doxorubicin (Doxil)FDA Link 11/2017 - 03/2002
13	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
8	Liposomes (Liposome)IBA 05/2022 - 03/2002
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 10/2010
8	salicylhydroxamic acid (SHAM)IBA 01/2020 - 05/2004
8	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 09/2002
7	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 08/2007
6	Acetic Acid (Vinegar)FDA LinkGeneric 07/2009 - 08/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2015
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 08/2007
5	Contrast MediaIBA 11/2019 - 12/2002
5	Ethanol (Ethyl Alcohol)IBA 07/2009 - 08/2003
4	CytokinesIBA 02/2020 - 12/2011
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2018 - 12/2010
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2016 - 08/2015
3	Angiogenesis InhibitorsIBA 10/2010 - 08/2007
3	Arsenic Trioxide (Trisenox)FDA Link 06/2007 - 03/2004
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2006 - 07/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2013
2	PlacebosIBA 01/2018 - 04/2016
2	1-dodecylpyridoxal (PLD)IBA 10/2017 - 01/2014
2	Small Interfering RNA (siRNA)IBA 01/2015 - 03/2012
2	Bortezomib (Velcade)FDA Link 12/2014 - 08/2008
2	QuercetinIBA 01/2014 - 06/2012
2	N 30IBA 04/2010 - 11/2008
1	cyclopropapyrroloindoleIBA 01/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	IronIBA 01/2021
1	ElastinIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 02/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	ferric oxide (iron oxide)IBA 11/2019
1	sebacic acidIBA 11/2019
1	ricinoleic acid (ricinelaidic acid)IBA 11/2019
1	iodixanol (Visipaque)FDA Link 11/2019
1	PolymersIBA 11/2019
1	GelsIBA 05/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	CurcuminIBA 01/2018
1	NSC 74859IBA 01/2018
1	Peptides (Polypeptides)IBA 11/2017
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2017
1	Antihypertensive Agents (Antihypertensives)IBA 07/2016
1	AldosteroneIBA 07/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016

Therapy/Procedure

51	Radiofrequency Ablation 01/2022 - 03/2002
46	Therapeutics 01/2021 - 07/2002
14	Electrodes (Electrode) 01/2018 - 03/2002
10	Aftercare (After-Treatment) 02/2020 - 03/2008
10	Drug Therapy (Chemotherapy) 01/2018 - 07/2002
7	Lasers (Laser) 07/2009 - 09/2002
4	Cryosurgery 07/2009 - 08/2003
3	Hepatectomy 01/2021 - 07/2010
3	Injections 11/2019 - 08/2003
2	Radiotherapy 01/2019 - 04/2005
1	Conservative Treatment 02/2022
1	Appendectomy 02/2022
1	Duration of Therapy 01/2022
1	Salvage Therapy 01/2021
1	Induced Hyperthermia (Thermotherapy) 01/2020
1	Retreatment 01/2019
1	CT protocol 11/2018
1	Nephrectomy 11/2018
1	Ablation Techniques 03/2017
1	Adrenalectomy 07/2016